TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Emergent BioSolutions Inc.
Emergent BioSolutions Launches BioThrax.com, an Educational Website about BioThrax Anthrax Vaccine Adsorbed and Anthrax Disease
May 26th, 2009
Emergent BioSolutions Inc. (NYSE:EBS) announced the launch of www.biothrax.com, a website that provides information about BioThrax® (Anthrax Vaccine Adsorbed), the only vaccine licensed by the U.S. Food and Drug Administration (FDA) for the prevention of anthrax infection. This new website educates visitors about key information on BioThrax, including published data and updates to prescribing information. In December 2008, the FDA approved the five-dose schedule and intramuscular route of administration for BioThrax. “Information about recent product enhancements such as the five-dose schedule and intramuscular route of administration is made readily available on...
Source: TB & Outbreaks Week (2009-05-26)
|
